Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mynd Life Sciences Inc (MYND.CN)

Mynd Life Sciences Inc (MYND.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MYND.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.600 +25.00%
on 08/25/21
1.000 -25.00%
on 08/30/21
+0.050 (+7.14%)
since 08/13/21
3-Month
0.600 +25.00%
on 08/25/21
2.050 -63.41%
on 06/18/21
-1.300 (-63.41%)
since 06/17/21

Most Recent Stories

More News
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering

/PRNewswire/ - (CSE: MYND) (OTC: MYNDF) ("" or the "") is pleased to announce, further to its news release of , the closing of its non-brokered private placement offering (the "") under which it sold...

MYND.CN : 0.750 (unch)
MYNDF : N/A (unch)
MYND Life Sciences Announces $3 Million Convertible Debenture Unit Offering

/PRNewswire/ - (CSE: MYND) (OTC: MYNDF) ("" or the ""), is pleased to announce that it has entered into a binding term sheet in respect of a non-brokered private placement offering (the "") of debenture...

MYND.CN : 0.750 (unch)
MYNDF : N/A (unch)
MYND Life Sciences Announces DTC Eligibility

/PRNewswire/ - (CSE: MYND) (OTC: MYNDF)is a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals and vaccines is pleased to announce...

MYND.CN : 0.750 (unch)
MYNDF : N/A (unch)
Stocks in play: MYND Life Sciences Inc.

Provided a corporate update on its operations and progress on its strategic initiatives to the end of ...

MYND.CN : 0.750 (unch)
This Key Psychedelic Could Revolutionize Depression Treatment for Millions

Mental health is on the decline all over the world. At the moment, nearly 264 million people are ...

CYBN : 2.16 (-3.14%)
CLXPF : 3.0200 (-1.31%)
MNMD : 2.45 (+0.41%)
NMED : 0.0001 (unch)
CMPS : 33.14 (-0.66%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
MYND.CN : 0.750 (unch)
MYND Life Sciences Provides Corporate Update

/PRNewswire/ - (CSE: MYND) is a drug research and development company focused on novel psychedelic drug development, diagnostic approaches, pharmaceuticals and vaccines, is pleased to provide a corporate...

MYND.CN : 0.750 (unch)
MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer's disease and related forms of Dementia with Chemical Subclasses of Psilocybin Analogues

/PRNewswire/ -  (CSE: MYND) ("") a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has expanded...

MYND.CN : 0.750 (unch)
MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics

/PRNewswire/ -  (CSE: MYND) ("") a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce a Letter of...

MYND.CN : 0.750 (unch)
MYND Life Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

/PRNewswire/ -  (CSE: MYND) ("") a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce that CEO, Dr....

MYND.CN : 0.750 (unch)
Stocks in play: MYND Life Sciences Inc.

Announced it has filed additional provisional patents that utilize various psilocybin analogs to target ...

MYND.CN : 0.750 (unch)

Key Turning Points

3rd Resistance Point 0.750
2nd Resistance Point 0.750
1st Resistance Point 0.750
Last Price 0.750
1st Support Level 0.750
2nd Support Level 0.750
3rd Support Level 0.750

See More

52-Week High 2.500
Fibonacci 61.8% 1.774
Fibonacci 50% 1.550
Fibonacci 38.2% 1.326
Last Price 0.750
52-Week Low 0.600

See More

Business Summary

MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar